Source: BioPortfolio

VET-STEM: VetStem Biopharma Enters Pet Cancer Field with Key License from Leading Human Cancer Company Calidi Biotherapeutics

VetStem Biopharma has licensed a highly promising oncolytic virus cancer therapy platform from Calidi Biotherapeutics for use in veterinary medicine.POWAY Calif. PRWEB July 18 2019 VetStem Biopharma has long been a leader in veterinary stem cell therapy w...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more